Iffy economy tempers view of 2002

Article

Fewer independent pharmacy owners and drugstore executives are optimistic about their economic prospects in 2002, according to a Drug Topics survey.

 

COVER STORY

Iffy economy tempers view of 2002

The majority of community pharmacy owners and executives think the year ahead will be a good one, but the downward trend of managed care fees and general stagnation have taken some air out of the economic engine's tires.

Sixty-three percent of independent pharmacy owners and 58% of chain executives predicted 2002 will yield good to excellent results. That's still pretty optimistic, until it's compared with the 74% of independents and 77% of chains who were upbeat about the 2001 business climate. The biggest business bummer they identified was managed care's how-low-can-you-go reimbursement. Many independents also mentioned the mail-order menace, while more chains see the R.Ph. shortage as a drag.

In the sales department, 55% of independents and 75% of chains expect cash registers will ring more next year. The median sales hike anticipated is 10%. Another 35% of independents foresee a sales status quo, and 10% are bracing for a sales downturn. Among chains, 16% think sales will be flat and 9% expect a dip.

Sales will go up, but so will overhead, according to 60% of independents and 63% of chains. The largest component of operating expenses—R.Ph.s' wages—is going to get larger in 2002, according to 69% of independents and 91% of chains. Independents expect average pay hikes of 8%, while chains put wage inflation at 7%. Only 15% of independents and 39% of chains plan to hire more staff.

The main source of revenue in 2002 will remain private insurance plans, accounting for 47% of the average independent's business next year, about the same as this year. Chains expect 63% of revenue to come from third parties, about the same as this year. Cash customers will account for only 20% of revenues among independents—the same as this year—and 15% in chains. Medicaid will provide 31% of independents' revenue and 18% of chains' income.

With the winds of economic fortune shifting to the north, independents and chains anticipate financial chills from several directions. The chief negative factor for 88% of independents and chains is Medicaid reimbursement cuts. President Bush's Medicare discount drug card is bad news to 79% of independents and 88% of chains. Meeting next year's deadline for compliance with Health Insurance Portability & Accountability Act's (HIPAA) claim transaction regulations is worrisome to 52% of independents and 82% of chains.

There isn't much ahead that's worth a thumbs-up, but falling interest rates are a plus for 42% of independents and 71% of chains. Also, Rx drugs offer moderate sales growth potential, according to 43% of independents and 56% of chains.

Carol Ukens

HOW DOES 2002 SHAPE UP?

 
Poor
Fair
Good
Very Good
Excellent
Chains
14%
28%
42%
11%
5%
Independents
4
33
43
16
4

WHAT’S AHEAD FOR NET PROFITS IN 2002?

 
Increase
Decrease
Remain the same
Chains
39%
33%
28%
Independents
22
33
45

 



Carol Ukens. Iffy economy tempers view of 2002.

Drug Topics

2001;23:32.

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.